The Multi-Channel Electrophysiological Recording System market outlook remains highly attractive, driven by rising demand for advanced neural research and clinical applications. Growth is fueled by increasing prevalence of neurological disorders and advancements in neurotechnology. Competitive intensity is moderate, with established players like Neuralynx and Blackrock Microsystems dominating, while emerging innovators leverage niche applications to differentiate. The long-term outlook is optimistic, underpinned by aging populations and chronic disease trends, which will sustain R&D investments. The innovation landscape is dynamic, with trends toward miniaturization, wireless systems, and AI-integrated solutions enhancing precision and usability. Demand–supply balance is currently stable, though rising demand from academic and pharmaceutical sectors may create temporary shortages. However, key risk factors include regulatory hurdles, high capital costs, and rapid technological obsolescence. Strategic collaborations and R&D focus on scalable, cost-effective designs will be critical to mitigating these risks and capitalizing on market opportunities.